Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes
This study is ongoing, but not recruiting participants.
Study NCT00338949 Information provided by National Institute of Mental Health (NIMH)
First Received: June 16, 2006 Last Updated: March 10, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Schizophrenia
Metabolic Syndrome X
Insulin Resistance
Additional conditions recognized in this trial
Syndrome
More general conditions related to this trial
Disease
Glucose Metabolism Disorders
Hyperinsulinism
Mental Disorders
Metabolic Diseases
Pathologic Processes
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
Ziprasidone
Additional drug interventions recognized in this trial
Antipsychotic Agents
More general drug interventions related to this trial
Central Nervous System Agents
Central Nervous System Depressants
Dopamine Agents
Dopamine Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Antagonists
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
National Institute of Mental Health (NIMH)
Back to top of Main Content
